Cargando…
Pulmonary embolism in coronavirus disease 2019: the silent killer
BACKGROUND: Pulmonary embolism (PE) has been identified as one of the deadliest complications of coronavirus disease 2019 (COVID-19), especially in patients admitted to the intensive care unit (ICU). Western literature reminds us of the high prevalence of PE in COVID. Here, we report a series of 13...
Autores principales: | Marwah, Vikas, Peter, Deepu K, Malik, Virender, Mishra, Satish Chandra, Kumar, Tentu Ajai, Kumar, Arvind, Bhati, Gaurav, Kumar, Nikhil, Singh, Shalendra, Choudhary, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313079/ https://www.ncbi.nlm.nih.gov/pubmed/34334899 http://dx.doi.org/10.1016/j.mjafi.2021.03.025 |
Ejemplares similares
-
Multidrug-resistant tuberculosis in COVID-19: Double trouble
por: Marwah, Vikas, et al.
Publicado: (2021) -
Clinico-etiological characteristics of organizing pneumonia: A retrospective study
por: Marwah, Vikas, et al.
Publicado: (2021) -
COVID-19 ARDS-related pneumomediastinum and pneumothorax
por: Marwah, Vikas, et al.
Publicado: (2021) -
Early experience with anti-interleukin-6 therapy in COVID-19 hyperinflammation
por: Marwah, Vikas, et al.
Publicado: (2021) -
Diagnostic Yield and Safety of Bronchoscopic Lung Cryobiopsy in Evaluation of Lung Mass
por: Babu PS, Shafin, et al.
Publicado: (2021)